LSI Seminar Series: Wen-Xing Ding, Ph.D., University of Kansas Medical Center
Wen-Xing Ding is a professor in the Department of Pharmacology, Toxicology and Therapeutics at The University of Kansas Medical Center. He received his Ph.D. from the National University of Singapore in 2002 and completed his postdoctoral training at the University of Pittsburgh. Ding has devoted his research career to elucidating mechanisms for regulation of cell death and the adaptive response to cellular injury in the liver. Since 2009, his laboratory has been working on the role of autophagy in alcohol- and drug-induced liver injury. They are particularly interested in how autophagy selectively removes cellular damaged/excess organelles, such as mitochondria and lipid droplets in hepatocytes. Ding has published more than 120 papers in peer-reviewed journals, and his work is currently supported by NIAAA and NIDDK.
In addition to research, Ding has demonstrated outstanding leadership for service. He has been a program committee member of ASIP (American Society of Investigative Pathology) and the AASLD (American Association for the Studies of Liver Disease) 2015 annual meeting. He organized several meetings and symposia for EB meeting, AASLD and GRC. He serves as an associate editor for the journal Autophagy and an editorial board member for several journals, including Hepatology, Cell and the American Journal of Pathology. He also serves as an ad hoc reviewer for NIH grants and a standing member of XNDA.